Tran, J. & Ornstein, M. C. Clinical review on the management of metastatic renal cell carcinoma. JCO Oncol. Pract. 18, 187–196 (2022).
Linehan, W. M., Srinivasan, R. & Schmidt, L. S. The genetic basis of kidney cancer: a metabolic disease. Nat. Rev. Urol. 7, 277–285 (2010).
Article CAS PubMed PubMed Central Google Scholar
The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43–49 (2013).
Article PubMed Central Google Scholar
Hu, J. et al. Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression. Nat. Genet. 56, 442–457 (2024).
Article CAS PubMed PubMed Central Google Scholar
Ericsson, J. L., Seljelid, R. & Orrenius, S. Comparative light and electron microscopic observations of the cytoplasmic matrix in renal carcinomas. Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 341, 204–223 (1966).
Article CAS PubMed Google Scholar
Li, Y. et al. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell 41, 139–163.e17 (2023).
Article CAS PubMed Google Scholar
Hakimi, A. A. et al. An integrated metabolic atlas of clear cell renal cell carcinoma. Cancer Cell 29, 104–116 (2016).
Article CAS PubMed PubMed Central Google Scholar
Ricketts, C. J. et al. The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep. 23, 313–326.e5 (2018).
Article CAS PubMed PubMed Central Google Scholar
Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discov. 21, 141–162 (2022).
留言 (0)